Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-01-22

Clinical Trial Update: To Assess the Effect of Dexamethasone Eye Drops on the Retinopathy of Prematurity Outcome

View source ↗

Summary

A completed clinical trial evaluated whether dexamethasone eye drops affect outcomes in retinopathy of prematurity.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dexamethasone ophthalmic solution (dexamethasone)

Snippet

Sponsor: Region Skane | Conditions: Retinopathy of Prematurity (ROP) | Status: COMPLETED